Finance

Lists
Why is ATHE down 3.29%?
Dive Deeper
ATHE:NASDAQ
Alterity Therapeutics Ltd
US$2.16
-3.29%
(-0.073) 1D
ኦክቶ 30, 3:00:00 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATHE...
Open
US$2.23
High
US$2.24
Low
US$2.11
Mkt. cap
40.70 ሚ
Avg. vol.
24.93 ሺ
Volume
9.06 ሺ
52-wk high
US$5.89
52-wk low
US$2.02
EPS
-US$0.94
Beta
0.29
Shares outstanding
19.10 ሚ
No. of employees
11
Open
US$2.23
High
US$2.24
Low
US$2.11
Mkt. cap
40.70 ሚ
Avg. vol.
24.93 ሺ
Volume
9.06 ሺ
52-wk high
US$5.89
52-wk low
US$2.02
EPS
-US$0.94
Beta
0.29
Shares outstanding
19.10 ሚ
No. of employees
11
News stories
From web sources and news partners
Bloomberg.com
Bloomberg.com
·
ከ47 ደቂቃዎች በፊት
Asian Stocks to Fall as Tech Rout Fuels AI Fears: Markets Wrap
https://tech-insider.org/
https://tech-insider.org/
·
ከ14 ደቂቃዎች በፊት
AI Capex Boom: $828B Spend, Nasdaq Down 2.9% [2026]
www.tokenpost.com
www.tokenpost.com
·
ከ1 ሰዓት በፊት
Nasdaq Falls 2.86% as U.S. Markets Enter Election and Earnings Week
Yahoo Finance
Yahoo Finance
·
ከ2 ሰዓቶች በፊት
Wall Street Has Never Faced This Many Market Forces at Once, NYSE Veteran Says
About Alterity Therapeutics Ltd
CEO-
Employees11
Founded1997
Headquartersመልበርን, Victoria, አውስትራልያ
SectorBiotechnology
Websitealteritytx.com
Analyst ratings
Based on 3 analysts giving stock ratings to ATHE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ATHE in the last 3 months.
Highest
Current US$2.16
US$16.00 (+640.74%)
Average
US$13.67 (+532.87%)
Lowest
US$10.00 (+362.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
US$10.00
+363%
10/05/2026
Adam Vogel
Craig-Hallum
Buy
Reiterated
US$15.00
+594.4%
10/05/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
US$16.00
+640.7%
08/28/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
US$10.00
+363%
06/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Initiated
US$10.00
+363%
06/16/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
US$12.00
+455.6%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
1.40 ሚ
1.40 ሚ
403.29 ሺ
403.29 ሺ
Cost of goods sold
49.43 ሺ
49.43 ሺ
81.96 ሺ
81.96 ሺ
Cost of revenue
49.43 ሺ
49.43 ሺ
81.96 ሺ
81.96 ሺ
Research and development expenses
3.92 ሚ
3.92 ሚ
4.89 ሚ
4.89 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.56 ሚ
2.56 ሚ
2.71 ሚ
2.71 ሚ
Operating expense
6.57 ሚ
6.57 ሚ
7.65 ሚ
7.65 ሚ
Total operating expenses
6.62 ሚ
6.62 ሚ
7.73 ሚ
7.73 ሚ
Operating income
-5.22 ሚ
-5.22 ሚ
-7.32 ሚ
-7.32 ሚ
Other non operating income
-
-
-
-
EBT including unusual items
-4.78 ሚ
-4.78 ሚ
-6.87 ሚ
-6.87 ሚ
EBT excluding unusual items
-4.78 ሚ
-4.78 ሚ
-6.87 ሚ
-6.87 ሚ
Income tax expense
30.78 ሺ
30.78 ሺ
25.97 ሺ
25.97 ሺ
Effective tax rate
-0.64%
-0.64%
-0.38%
-0.38%
Other operating expenses
95.67 ሺ
95.67 ሺ
46.26 ሺ
46.26 ሺ
Net income
-4.81 ሚ
-4.81 ሚ
-6.89 ሚ
-6.89 ሚ
Net profit margin
-343.00%
-343.00%
-1,709.06%
-1,709.06%
Earnings per share
-
-
-
-
Interest and investment income
454.88 ሺ
454.88 ሺ
403.45 ሺ
403.45 ሺ
Interest expense
-
-
-
-
Net interest expenses
454.88 ሺ
454.88 ሺ
403.45 ሺ
403.45 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.22 ሚ
-5.22 ሚ
-7.32 ሚ
-7.32 ሚ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች